Twist Bioscience Corporation
TWST
Classifica tra le azioni
#2140
Twist Bioscience Corporation operates as a leading synthetic biology firm,... Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
Prezzo delle azioni
$144.87
Ultima sincronizzazione: 2026-10-20
Capitalizzazione di mercato
$9.54B
Variazione (1 giorno)
3.65%
Variazione (1 anno)
333.86%
Paese
US
Scambia Twist Bioscience Corporation (TWST)
Categoria
Healthcare
Ricavi di Twist Bioscience Corporation (TWST)
Ricavi nel Jun 2026 TTM: $431.80M
Secondo gli ultimi rapporti finanziari di Twist Bioscience Corporation, i ricavi attuali dell'azienda (TTM) sono pari a $431.80M. Nel 2024, l'azienda ha registrato ricavi di $312.97M un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $245.11M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Twist Bioscience Corporation da 2016 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $431.80M | 14.67% |
| 2025 | $376.57M | 20.32% |
| 2024 | $312.97M | 27.69% |
| 2023 | $245.11M | 20.41% |
| 2022 | $203.57M | 53.83% |
| 2021 | $132.33M | 46.87% |
| 2020 | $90.10M | 65.67% |
| 2019 | $54.39M | 113.89% |
| 2018 | $25.43M | 136.16% |
| 2017 | $10.77M | 374.53% |
| 2016 | $2.27M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $46.34B | 10,630.94% |
US
|
|
| $25.11B | 5,714.52% |
US
|
|
| $2.71B | 526.93% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 1,607.28% |
US
|
